Pomerantz LLP is investigating claims on behalf of investors ofDuolingo, Inc. (“Duolingo” or the “Company”)(NASDAQ: DUOL).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whetherDuolingo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the […]

Pomerantz LLP is investigating claims on behalf of investors ofMolina Healthcare, Inc. (“Molina” or the “Company”)(NYSE: MOH).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whetherMolina and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining

Pomerantz LLP is investigating claims on behalf of investors ofExelixis, Inc. (“Exelixis” or the “Company”)(NASDAQ: EXEL).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whetherExelixis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the

Kessler Topaz Meltzer & Check, LLP Reminds CHTR Investors of October 14, 2025 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm GlobeNewswire September 13, 2025 RADNOR, Pa., Sept. 13, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a

Pomerantz LLP is investigating claims on behalf of investors ofNeoGenomics, Inc. (“NeoGenomics” or the “Company”)(NASDAQ: NEO).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whetherNeoGenomics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the

Pomerantz LLP is investigating claims on behalf of investors ofAnika Therapeutics, Inc. (“Anika” or the “Company”)(NASDAQ: ANIK).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whetherAnika and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining

Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. (“Praxis” or the “Company”) (NASDAQ: PRAX).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Praxis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click

Pomerantz LLP is investigating claims on behalf of investors of Albany International Corp. (“Albany” or the “Company”) (NYSE: AIN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Albany and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here

Pomerantz LLP is investigating claims on behalf of investors of PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether PACS and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here

Pomerantz LLP is investigating claims on behalf of investors of Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Freeport and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for